Related references
Note: Only part of the references are listed.The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury
Stefania Ceruti et al.
BRAIN (2009)
A Model of Ischemia-Induced Neuroblast Activation in the Adult Subventricular Zone
Davide Vergni et al.
PLOS ONE (2009)
GPR17: Molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors
Chiara Parravicini et al.
BMC BIOINFORMATICS (2008)
The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair
Davide Lecca et al.
PLOS ONE (2008)
Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors
Richard Einstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
Paolo Ciana et al.
EMBO JOURNAL (2006)
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats
S. H. Fang et al.
NEUROSCIENCE (2006)
International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
Maria P. Abbracchio et al.
PHARMACOLOGICAL REVIEWS (2006)
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
Ivar von Kuegelgen
PHARMACOLOGY & THERAPEUTICS (2006)
P2Y2 and P2Y4 receptors regulate pancreatic Ca2+-activated K+ channels differently
SE Hede et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
The platelet P2 receptors in thrombosis
C Gachet et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y13 receptor
M Fumagalli et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Pharmacological characterization of the human P2Y13 receptor
F Marteau et al.
MOLECULAR PHARMACOLOGY (2003)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
BK channel openers inhibit migration of human glioma cells
R Kraft et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2003)
International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors
C Brink et al.
PHARMACOLOGICAL REVIEWS (2003)
Principles:: Extending the utility of [35S]GTPγS binding assays
G Milligan
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
MP Abbracchio et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Spatial and temporal aspects of Ca2+ signaling mediated by P2Y receptors in cultured rat hippocampal astrocytes
S Koizumi et al.
LIFE SCIENCES (2002)
BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells
D Basrai et al.
NEUROREPORT (2002)
Molecular cloning and functional. characterization of murine cysteinyl-leukotriene 1 (CysLT1) receptors
V Martin et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Production of leukotrienes in a model of focal cerebral ischaemia in the rat
P Ciceri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Functional characterization of a human receptor for neuropeptide FF and related peptides
M Kotani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Serum deprivation and NGF induce and modulate voltage-gated Na+ currents in human astrocytoma cell lines
R Kraft et al.
GLIA (2001)
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels
VK Gribkoff et al.
NATURE MEDICINE (2001)
Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing
A Maekawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)